Kaehler, K. C., Blome, C., Forschner, A., Gutzmer, R., Haalck, T., Heinzerling, L., . . . Augustin, M. (2016). Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG “GERMELATOX survey”) versus melanoma recurrence to quantify patients’ relative values for adjuvant therapy. Medicine (Baltimore).
Chicago Style CitationKaehler, Katharina C., et al. "Preferences of German Melanoma Patients for Interferon (IFN) α-2b Toxicities (the DeCOG “GERMELATOX Survey”) Versus Melanoma Recurrence to Quantify Patients’ Relative Values for Adjuvant Therapy." Medicine (Baltimore) 2016.
Cita MLAKaehler, Katharina C., et al. "Preferences of German Melanoma Patients for Interferon (IFN) α-2b Toxicities (the DeCOG “GERMELATOX Survey”) Versus Melanoma Recurrence to Quantify Patients’ Relative Values for Adjuvant Therapy." Medicine (Baltimore) 2016.